Tau Protein News and Research

RSS

Tau proteins are microtubule-associated proteins found in neurons in the brain.

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. While age is the greatest risk factor for developing the disease, researchers believe most Alzheimer's cases occur as a result of complex interactions among genes and other factors. But those factors and the role they play are not known--yet.

29 Jan 2019

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

The accumulation of amyloid beta plaques and tangles of a protein called tau in the brain are hallmarks of Alzheimer's disease.

27 Jan 2019

Researchers discover new changes occurring in the brain in early Alzheimer's disease

Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.

21 Dec 2018

Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

An ultrasensitive test has been developed that detects a corrupted protein associated with Alzheimer's disease and chronic traumatic encephalopathy, a condition found in athletes, military veterans, and others with a history of repetitive brain trauma.

20 Dec 2018

Tau protein reduces neural activity in Alzheimer's mouse models

A study from Massachusetts General Hospital investigators sheds new light on how the hallmarks of Alzheimer's disease - amyloid-beta (A-beta) plaques and neurofibrillary tangles containing the protein tau - produce their damaging effects in the brain.

19 Dec 2018

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Better tactics for detecting, preventing and treating Alzheimer's disease depend on a clearer understanding of cellular-level changes in the minds of patients, and a new study has uncovered novel details about the vulnerability of one type of brain cell.

18 Dec 2018

Research opens door to development of drug or vaccine for late-onset Alzheimer's

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

17 Dec 2018

Alzheimer's could possibly be spread via contaminated neurosurgery

Researchers have found that surgical instruments used for neurosurgery could get contaminated by the altered brain proteins that are seen in Alzheimer’s disease. These instruments are capable of spreading the condition if not treated or decontaminated properly before reuse. The study results were published in the latest issue of the journal Nature.

14 Dec 2018

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time - a form of personalized medicine for neurodegenerative diseases.

11 Dec 2018

Researchers identify potential diagnostic tool for Alzheimer’s disease

Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias.

11 Dec 2018

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Today, the only way to definitively diagnose Alzheimer's disease in life is through brain scans and tests of cerebrospinal fluid that must be collected via lumbar puncture. Though cumbersome and expensive, such tests provide the most accurate diagnoses for patients.

6 Dec 2018

Researchers uncover genes that lead to excessive tau in dementia

Researchers have identified two major groups of genes involved in the mutations that lead to excess production of tau, a protein involved in dementia.

3 Dec 2018

Researchers discover new information on pathological mechanisms of Alzheimer's disease

Researchers at the University of Helsinki have discovered a mechanism by which harmful tau protein aggregates are transmitted between neurons. Alongside amyloid plaques, tau aggregates in the brain are a significant factor in the progression of Alzheimer's disease.

20 Nov 2018

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Researchers have developed a new DNA vaccine that reduces the build-up of the toxic proteins associated with Alzheimer’s disease.

20 Nov 2018

Neuropsychiatric symptoms related to earliest stages of Alzheimer's brain pathology

UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer's disease are linked to neuropsychiatric symptoms including anxiety, depression, loss of appetite, and sleep disturbances.

15 Oct 2018

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Anthony Fitzpatrick, PhD, a Principal Investigator at Columbia's Zuckerman Institute and Columbia University Irving Medical Center, together with scientists from the Mayo Clinic and Boston Children's Hospital, has been awarded $11.3 million to map the three-dimensional structures of protein tangles that accumulate in the human brain.

11 Oct 2018

Tau Protein News and Research

Further Reading

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

Researchers discover new changes occurring in the brain in early Alzheimer's disease

Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

Tau protein reduces neural activity in Alzheimer's mouse models

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Research opens door to development of drug or vaccine for late-onset Alzheimer's

Alzheimer's could possibly be spread via contaminated neurosurgery

Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages

Researchers identify potential diagnostic tool for Alzheimer’s disease

Researchers are developing blood test to diagnose or predict Alzheimer's disease

Researchers uncover genes that lead to excessive tau in dementia

Researchers discover new information on pathological mechanisms of Alzheimer's disease

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Neuropsychiatric symptoms related to earliest stages of Alzheimer's brain pathology

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Alzheimer’s disease researchers makes significant breakthroughs

Alzheimer’s diagnosis might become simpler with new brain imaging method

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

Discovering Prion-like Proteins in Eukaryotic Viruses

Latest eBooks

Industry focus eBook - The Digital Laboratory (4th edition)

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation